TMD LAB received a Cooperative Research and Development Agreement (CRADA) proposal from the NIST and signed the agreement on October 11 2022. Both sides are expected to build a DNA database for various SMP materials through joint research and develop materials that further reduce the formation of biofilms, thereby enhancing the utility of SMP as implantable medical devices.
TMD LAB and the biomaterials group of NIST signed a confidential disclosure agreement for joint research in April last year. In addition, basic research on the structural properties of SMP of TMD LAB has been conducted.
The biomaterials group of NIST is composed of researchers specialized in various biomaterials and cell-to-cell interactions, microbial measurement, spectroscopy, etc. And they showed a lot of interest in the characteristics of SMP of TMD LAB, which led to the conclusion of CRADA (Cooperative Research and Development. Agreement).
SMP developed by TMD LAB can restore shape near body temperature and control the speed of shape recovery from several seconds to several minutes or more. In addition, it is characterized by reducing the formation of biofilms caused by microbial infection by 74% compared to silicon. TMD LAB is developing various medical devices inserted into the human body, such as non-vascular stents such as external vascular wrapping support and bile duct stent, ophthalmic devices, and plastic implants by utilizing the characteristics of these SMP.
Hak-Joon Sung, CEO of TMD LAB, explained, “I know that it is rare for NIST to sign a joint R&D agreement with a foreign private company. We expect that this joint research would facilitate the expansion of the market for implantable medical devices using SMP.”
About TMD LAB Co., Ltd.
TMD LAB Co., Ltd., established in 2018, is a company that is developing implantable medical devices using Shape Memory Polymer (SMP), high-tech new materials. It has the original technology of polymer synthesis with fast shape restoration near body temperature. Based on this technology, TMD LAB succeeded in performing a procedure with minimal wounds on the human body and resolving the biofilm problem of existing silicone materials.
TMD LAB CO., LTD.
Marketing & Sales Team
HUI GYEONG KIM
This news is a press release from the provider.
Korea Newswire is committed to verifying the transparency of providers and eliminating content errors.
You can receive press releases from this company or in industries of interest via email and RSS for free. Subscribe>
News provided byTMD LAB